WolverHeme Happy Hour cover image

Episode 13: You get blinatumomab! You get blinatumomab!

WolverHeme Happy Hour

00:00

The Effects of Blint on Survival in MRD Positive Patients

Blint works well at taking patients from MRD positive to MRD negative states, and it's the standard of care in that setting. But what we don't know is does it actually improve survival when we give it to MRD positive patients? And if we added it to MRd negative patients, would it also improve outcomes? Yes, very excellent summary. Patrick, I know we were approached, what, six, seven years ago, right around the time that you started at U of M to participate in the study. We're kind of kicking ourselves in the head because of that. So why don't you give us a little bit of background of what E-COG is and

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app